DONATE

New molecules allow to switch on and off neuronal circuits using light

Researchers from IBEC, in collaboration with an international team, describe the first molecules capable of regulate glycine receptors with light: Glyght and Azo-NZ1. The new molecules are a promising way to study neuronal circuits, to develop drug-based phototherapies non-invasively, and to understand neurological disorders related with the incorrect functioning of glycine receptors, as hyperekplexia, epilepsy and autism.

Online IBEC Seminar: Mónica Marro

A new molecular dimension: exploiting Raman spectroscopy in Biomedicine Mónica Marro, ICFO, The Institute of Photonic Sciences Raman spectroscopy is a promising optical technique that enables the investigation of the … Read more

IBEC’s Gambit

Taking risks is what science is about. You put all your efforts to pursue one objective and you can either lose or achieve your goal. But losing is not always … Read more

Satisfaction survey

Satisfaction Survey Please take a moment to rate the services provided by IBEC.

Towards a treatment for myotonic dystrophy: the first 3D model with patient cells

IBEC researchers led by Javier Ramón and Juan M. Fernández develop the first three-dimensional model for myotonic dystrophy, a rare disease that currently has no cure. The model combines patient cells and bioengineering techniques and represents a major advance over the use of animals and cell cultures. This new model will help in the design of personalized and more effective treatments, and for drug testing in a much more efficient way.

Postdoctoral position at the Targeted Therapeutics & Nanodevices Research Group


Application Deadline: 18/06/2021
Ref: PD-SM
The Targeted Therapeutics and Nanodevices Research group at the Institute for Bioengineering of Catalonia (IBEC) is looking for a Postdoctoral candidate to collaborate in a research project focused on the identification, characterization, and application of “universal” monoclonal antibodies capable of recognizing specific cell-surface receptors in a variety of species, as primary tools to then develop targeted drug delivery applications (nanoparticles and antibody-drug conjugates) for the treatment of neurodegenerative diseases.

The contract will be within the framework of the project “CROSSTARGET: Development of new translational cross-species tools for therapeutic targeting with organ and subcellular precision”, funded by the Ministerio de Ciencia, Innovación y Universidades under its RETOS program.

PhD Position in the Synthetic Morphogenesis group (IBEC, TU/e)


Application Deadline: 21/05/2021
Ref: PH- VC

The Institute for Bioengineering of Catalonia (IBEC) in collaboration with the Eindhoven University of Technology (TU/e, Eindhoven – Netherlands) are seeing an ambitious PhD Candidate to investigate the morphogenesis of living tissues from the computational perspective. The successful candidate will carry out computational research with the Synthetic Morphogenesis group under the supervision of Dr Vito Conte across both institutions at the interface between Biology, Physics, Engineering, Mathematics and Computer Sciences. This multidisciplinary doctoral research will be carried out in collaboration with Dr Jose Muñoz at the Polytechnic University of Catalonia (UPC, Barcelona – Spain) and will be part of greater efforts aiming at establishing a new Platform for the Live-Quantification of Cell and Tissue Mechanics across the IBEC and the TU/e.